Sk Biopharmaceutica (Korea) Price Prediction
| 326030 Stock | 102,100 1,500 1.45% |
Oversold Vs Overbought
38
Oversold | Overbought |
Using Sk Biopharmaceutica hype-based prediction, you can estimate the value of Sk Biopharmaceuticals Co from the perspective of Sk Biopharmaceutica response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Sk Biopharmaceutica to buy its stock at a price that has no basis in reality. In that case, they are not buying 326030 because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Sk Biopharmaceutica after-hype prediction price | KRW 102100.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
326030 |
Sk Biopharmaceutica After-Hype Price Prediction Density Analysis
As far as predicting the price of Sk Biopharmaceutica at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sk Biopharmaceutica or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sk Biopharmaceutica, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sk Biopharmaceutica Estimiated After-Hype Price Volatility
In the context of predicting Sk Biopharmaceutica's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sk Biopharmaceutica's historical news coverage. Sk Biopharmaceutica's after-hype downside and upside margins for the prediction period are 102,097 and 102,103, respectively. We have considered Sk Biopharmaceutica's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sk Biopharmaceutica is very steady at this time. Analysis and calculation of next after-hype price of Sk Biopharmaceuticals is based on 3 months time horizon.
Sk Biopharmaceutica Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Sk Biopharmaceutica is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sk Biopharmaceutica backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sk Biopharmaceutica, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.10 | 2.92 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
102,100 | 102,100 | 0.00 |
|
Sk Biopharmaceutica Hype Timeline
Sk Biopharmaceuticals is presently traded for 102,100on Korea Stock Exchange of Korea. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. 326030 is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.1%. %. The volatility of related hype on Sk Biopharmaceutica is about 0.0%, with the expected price after the next announcement by competition of 102,100. About 64.0% of the company shares are owned by insiders or employees . The company recorded a loss per share of 117.74. Sk Biopharmaceuticals had not issued any dividends in recent years. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days. Check out Sk Biopharmaceutica Basic Forecasting Models to cross-verify your projections.Sk Biopharmaceutica Related Hype Analysis
Having access to credible news sources related to Sk Biopharmaceutica's direct competition is more important than ever and may enhance your ability to predict Sk Biopharmaceutica's future price movements. Getting to know how Sk Biopharmaceutica's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sk Biopharmaceutica may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 298380 | ABL Bio | 0.00 | 0 per month | 0.00 | (0.02) | 7.75 | (5.24) | 26.64 | |
| 196170 | ALTEOGEN | 0.00 | 0 per month | 0.00 | (0.02) | 9.55 | (7.44) | 30.73 | |
| 032500 | Kmw Inc | 0.00 | 0 per month | 3.10 | 0.05 | 7.10 | (5.60) | 16.80 | |
| 068760 | Celltrion Pharm | 0.00 | 0 per month | 0.00 | (0.06) | 4.59 | (5.48) | 16.29 |
Sk Biopharmaceutica Additional Predictive Modules
Most predictive techniques to examine 326030 price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for 326030 using various technical indicators. When you analyze 326030 charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Sk Biopharmaceutica Predictive Indicators
The successful prediction of Sk Biopharmaceutica stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sk Biopharmaceuticals Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sk Biopharmaceutica based on analysis of Sk Biopharmaceutica hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sk Biopharmaceutica's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sk Biopharmaceutica's related companies.
Story Coverage note for Sk Biopharmaceutica
The number of cover stories for Sk Biopharmaceutica depends on current market conditions and Sk Biopharmaceutica's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sk Biopharmaceutica is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sk Biopharmaceutica's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Sk Biopharmaceutica Short Properties
Sk Biopharmaceutica's future price predictability will typically decrease when Sk Biopharmaceutica's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sk Biopharmaceuticals Co often depends not only on the future outlook of the potential Sk Biopharmaceutica's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sk Biopharmaceutica's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 78.3 M |
Complementary Tools for 326030 Stock analysis
When running Sk Biopharmaceutica's price analysis, check to measure Sk Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sk Biopharmaceutica is operating at the current time. Most of Sk Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sk Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sk Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sk Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |